Adams Julian's most recent trade in Elicio Therapeutics Inc. was a trade of 7,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elicio Therapeutics Inc. | Julian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 7,900 | 7,900 | - | - | Stock Option (Right to Buy) | |
| Elicio Therapeutics Inc. | Julian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 4,100 | 4,100 | - | - | Stock Option (Right to Buy) | |
| Gamida Cell Ltd | Julian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 423,750 | - | 0 | Ordinary Shares | |
| Elicio Therapeutics Inc. | Adams Julian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 4,100 | 4,100 | - | - | Stock Option (right to buy) | |
| Gamida Cell Ltd | Julian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 56,600 | 56,600 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Julian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,300 | 223,750 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Julian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 9,500 | 9,500 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Julian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 2,000 | 195,450 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Julian Adams | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2022 | 291,100 | 291,100 | - | - | Employee Share Option (Right to Buy) | |
| Gamida Cell Ltd | Julian Adams | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2022 | 68,800 | 193,450 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Julian Adams | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2022 | 48,500 | 124,650 | - | 0 | Ordinary Shares |